Remifentanilic acid
Appearance
![]() | |
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
UNII | |
Chemical and physical data | |
Formula | C19H26N2O5 |
Molar mass | 362.426 g·mol−1 |
3D model (JSmol) | |
| |
|
Remifentanilic acid is a metabolite of the potent short-acting synthetic opioid analgesic drug remifentanil. It is an analog of fentanyl and remifentanil, but is not active as an opioid in its own right.[1][2][3][4][5][6][7][8]
See also
[edit]- 3-Methylbutyrfentanyl
- 4-Fluorobutyrfentanyl
- 4-Fluorofentanyl
- α-Methylfentanyl
- Acetylfentanyl
- Benzylfentanyl
- Furanylfentanyl
- Homofentanyl
- List of fentanyl analogues
References
[edit]- ^ Pitsiu, M.; et al. (2004). "Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment". British Journal of Anaesthesia. 92 (4): 493–503. doi:10.1093/bja/aeh086. PMID 14766712.
- ^ Battershill, Anna J. (2006). "Remifentanil". Drugs. 66 (3): 365–385. doi:10.2165/00003495-200666030-00013. PMID 16526829.
- ^ Kan, Randall E. (1998). "Intravenous remifentanil: placental transfer, maternal and neonatal effects". The Journal of the American Society of Anesthesiologists. 88 (6): 1467–1474. doi:10.1097/00000542-199806000-00008. PMID 9637638. S2CID 23854808.
- ^ Glass, Peter SA (1999). "A review of the pharmacokinetics and pharmacodynamics of remifentanil". Anesthesia & Analgesia. 89 (4S): 7. doi:10.1097/00000539-199910001-00003. PMID 10511072.
- ^ Nan, Zhang (2020). "Spectral Analysis and Structural Identification of Remifentanil Acid". Guangpuxue Yu Guangpu Fenxi/Spectroscopy and Spectral Analysis: 2059-2065.
- ^ Kuhlen, Ralf (2003). "Remifentanil for analgesia-based sedation in the intensive care unit". Critical Care. 8 (1): 1-3. PMC 420067.
- ^ Owen, Medge D. (2002). "Prolonged intravenous remifentanil infusion for labor analgesia". Anesthesia & Analgesia. 94 (4): 918–9, table of contents. doi:10.1097/00000539-200204000-00027. PMID 11916797.
- ^ Riches, James R. (2012). "Analysis of clothing and urine from Moscow theatre siege casualties reveals carfentanil and remifentanil use". Journal of Analytical Toxicology. 36 (9): 647–656. doi:10.1093/jat/bks078. PMID 23002178.
Further reading
[edit]- Higashikawa Y, Suzuki S (June 2008). "Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues". Forensic Toxicology. 26 (1): 1–5. doi:10.1007/s11419-007-0039-1. S2CID 22092512.
- Alburges ME, Hanson GR, Gibb JW, Sakashita CO, Rollins DE (1992). "Fentanyl receptor assay. II. Utilization of a radioreceptor assay for the analysis of fentanyl analogs in urine". J Anal Toxicol. 16 (1): 36–41. doi:10.1093/jat/16.1.36. PMID 1322477.
- Woods J, Medzihradsky F, Smith C, Winger G, Gmerek D (1988). "Evaluation of new compounds for opioid activity: 1987 annual report". NIDA Res. Monogr. 81: 543–90. PMID 3136388.
- Aceto M, Bowman E, Harris L, May E (1988). "Dependence studies of new compounds in the rhesus monkey, rat, and mouse, 1987". NIDA Res. Monogr. 81: 485–542. PMID 3136386.
- Brine GA, Boldt KG, Huang PT, Sawyer DK, Carroll FI (2009). "Carbon-13 nuclear magnetic resonance spectra of fentanyl analogs". Journal of Heterocyclic Chemistry. 26 (3): 677–686. doi:10.1002/jhet.5570260329.